Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.
Newsweek, the modern global digital news organization, in partnership with Plant-A Insights Group and GIST Impact, announced its annual America's Greenest Companies rankings today. This second annual ...